Fisher And Paykel Healthcare Corpo revenue and financials

FPH · ASX · AUD

$37.69+0.96%+$0.36

Close · October 7, 2026

In the fiscal year ended March 2026, Fisher And Paykel Healthcare Corpo reported revenue of $2.31B (+80.30% year over year). Net income was $468.5M, a net margin of 20.3%.

Annual revenue · 2026: $2.31B

$1.59B2023
$1.76B2024
$1.28B2025
$2.31B2026

Fiscal year ending in March. Sources and method on the page Methodology and sources.

At a glance

Revenue growth: +80.30%; FY to Mar 2026 vs FY to Mar 2025
Net income growth: +24.20%; FY to Mar 2026 vs FY to Mar 2025
Net margin: 20.3%; FY to Mar 2025: 29.5%

Financial data

Amounts in millions of NZD; per-share values in NZD; shares in millions.

Income statement · Annual
Item	FY to Mar 2026	FY to Mar 2025	FY to Mar 2024	FY to Mar 2023
Total revenue	2,308	1,280	1,758	1,589
Cost of revenue	838	750	698	643
Gross profit	1,470	530	1,060	946
Selling, general and administrative	598	534	493	432
Research and development	236	227	198	174
Operating income	478	-371	254	241
EBIT	642	514	254	335
EBITDA	800	654	368	434
Interest expense	10.3	11.1	18.2	6.7
Pre-tax income	632	503	236	328
Income tax	163	126	103	77.7
Net income	469	377	133	250
Net income to common shareholders	469	377	133	250
Basic EPS	0.80	0.64	0.23	0.43
Diluted EPS	0.79	0.64	0.23	0.43
Average shares (basic)	587	586	582	578
Average shares (diluted)	591	590	587	582